Abstract:
This paper focuses on the effect of globalization and western hegemony, and its
manifestations on pharmaceutical industry that is closely linked to global health conditions in
the world. On a more specific note, Lebanon is one of the numerous developing countries
directly implicated by the globalization of public health and its industry. This thesis examines
the ability of small nation states to develop sound health policies without being influenced by
powerful global pharmaceutical industries. Based on existing survey data and in-depth
interviews with key stakeholders in key pharmaceutical companies, Lebanese Ministry of
Public Health, and relevant syndicates this thesis reveals major challenges and opportunities
for the advancement of the Lebanese public health system. Findings point to the centrality of
civil society to provide critical oversight roles over public-international partnerships
agreements. Civil society’s abilities to influence health policy agenda and provide early
public warnings about health threats and appropriate responses represent a national safeguard
for global engagement. Lebanese civil society’s “Think Again”, a part of the National
Cervical Cancer Prevention Campaign, implemented in collaboration with the Ministry of
Public Health and the international pharmaceutical companies demonstrates best practices in
this sector.
